PATENT CLAIM ANALYSIS

Application Number: 16438135
Application Type: Utility
Filing Date: 2019-06
Publication Date: 2019-10
Patent Classification: ["544", "281000"]

Abstract:
Compounds of Formula (00A) and methods of use as Janus kinase inhibitors are described herein.

Claim (Index 17):
A method of preventing, treating or lessening the severity of a disease or condition responsive to the inhibition of a Janus kinase activity in a patient, comprising administering to the patient a therapeutically effective amount of a compound of  claim 1 .

Metadata:
- Claim Count in Document: 50.0
- Percentile: 100.0
- Lexical Diversity: 1.05882
- Patent Class: 544.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15139164', '15543826', '14904801', '14451600', '15257926']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7688214600811564
- 35 USC 102 Novelty (BERT): 0.5741686212995847
- Combined Prediction Score: 0.7493561762029992
- Mean Citation Score: 405.063252
- Max Citation Score: 495.0762
- Similarity Product: 374.6440687622309

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test